27 April 2011

Let the games begin

Earlier today, Pacific Biosciences (Menlo Park, CA) announced that they are now shipping their commercial single molecule, real-time PacBio RS sequencing systems. In the press release, PacBio claim that their new technology "allows customers to obtain results in less than a day", compared to the week+ it takes to obtain data from other sequencing technologies. While papers, talks, and videos of PacBio technology has certainly created a buzz among researchers, it will be interesting to see how this step affects business. NASDAQ:PACB stock closed at 11.60 today, lower than their $16 starting share price last October when they IPO'd.

No comments:

Post a Comment